Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis

被引:621
|
作者
Weinstein, James N. [1 ]
Lurie, Jon D.
Tosteson, Tor D.
Hanscom, Brett
Tosteson, Anna N. A.
Blood, Emily A.
Birkmeyer, Nancy J. O.
Hilibrand, Alan S.
Herkowitz, Harry
Cammisa, Frank P.
Albert, Todd J.
Emery, Sanford E.
Lenke, Lawrence G.
Abdu, William A.
Longley, Michael
Errico, Thomas J.
Hu, Serena S.
机构
[1] Dartmouth Med Sch, Dept Orthopaed, Lebanon, NH 03756 USA
[2] Dartmouth Med Sch, Dept Med, Lebanon, NH USA
[3] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA
[6] William H Beaumont Hosp, Royal Oak, MI USA
[7] Hosp Special Surg, New York, NY 10021 USA
[8] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[9] Case Western Reserve Univ, Cleveland, OH 44106 USA
[10] Washington Univ, St Louis, MO 63130 USA
[11] Nebraska Fdn Hosp Spinal Res, Omaha, NE USA
[12] Hosp Joint Dis & Med Ctr, New York, NY USA
[13] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 22期
关键词
D O I
10.1056/NEJMoa070302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Management of degenerative spondylolisthesis with spinal stenosis is controversial. Surgery is widely used, but its effectiveness in comparison with that of nonsurgical treatment has not been demonstrated in controlled trials. METHODS: Surgical candidates from 13 centers in 11 U.S. states who had at least 12 weeks of symptoms and image-confirmed degenerative spondylolisthesis were offered enrollment in a randomized cohort or an observational cohort. Treatment was standard decompressive laminectomy (with or without fusion) or usual nonsurgical care. The primary outcome measures were the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) bodily pain and physical function scores (100-point scales, with higher scores indicating less severe symptoms) and the modified Oswestry Disability Index (100-point scale, with lower scores indicating less severe symptoms) at 6 weeks, 3 months, 6 months, 1 year, and 2 years. RESULTS: We enrolled 304 patients in the randomized cohort and 303 in the observational cohort. The baseline characteristics of the two cohorts were similar. The one-year crossover rates were high in the randomized cohort (approximately 40% in each direction) but moderate in the observational cohort (17% crossover to surgery and 3% crossover to nonsurgical care). The intention-to-treat analysis for the randomized cohort showed no statistically significant effects for the primary outcomes. The as-treated analysis for both cohorts combined showed a significant advantage for surgery at 3 months that increased at 1 year and diminished only slightly at 2 years. The treatment effects at 2 years were 18.1 for bodily pain (95% confidence interval [CI], 14.5 to 21.7), 18.3 for physical function (95% CI, 14.6 to 21.9), and -16.7 for the Oswestry Disability Index (95% CI, -19.5 to -13.9). There was little evidence of harm from either treatment. CONCLUSIONS: In nonrandomized as-treated comparisons with careful control for potentially confounding baseline factors, patients with degenerative spondylolisthesis and spinal stenosis treated surgically showed substantially greater improvement in pain and function during a period of 2 years than patients treated nonsurgically.
引用
收藏
页码:2257 / 2270
页数:14
相关论文
共 50 条
  • [31] Interbody Fusion Techniques in the Surgical Management of Degenerative Lumbar Spondylolisthesis
    Derman P.B.
    Albert T.J.
    Current Reviews in Musculoskeletal Medicine, 2017, 10 (4) : 530 - 538
  • [32] Perioperative Effects Associated With the Surgical Treatment of Degenerative Spondylolisthesis Interbody Versus No Interbody
    Colman, Matthew W.
    Baronne, Lon M., II
    Brodke, Darrel S.
    Woodbury, Ashley M.
    Annis, Prokopis
    Lawrence, Brandon D.
    CLINICAL SPINE SURGERY, 2019, 32 (02): : E71 - E77
  • [33] Posterolateral Versus Posterior Interbody Fusion in Lumbar Degenerative Spondylolisthesis
    Urquhart, Jennifer C.
    Alnaghmoosh, Nabeel
    Gurr, Kevin R.
    Bailey, Stewart I.
    Tallon, Corinne
    Dehens, Shauna
    Arellano, M. Patricia Rosas
    Bailey, Christopher S.
    CLINICAL SPINE SURGERY, 2018, 31 (09): : E446 - E452
  • [34] Transforaminal lumbar interbody fusion for the treatment of degenerative spondylolisthesis
    Quante, M.
    Kesten, H.
    Richter, A.
    Halm, H.
    ORTHOPADE, 2012, 41 (02): : 153 - +
  • [35] Exploring Surgeon Preference in the Treatment of Degenerative Lumbar Spondylolisthesis
    Winans, Nathan J.
    Khan, Farhan
    Chan, Andrew K.
    JAMA NETWORK OPEN, 2025, 8 (01)
  • [36] Surgical Treatment of Lumbar Spondylolisthesis in the Elderly
    Chakravarthy, Vikram
    Patel, Arpan
    Kemp, William
    Steinmetz, Michael
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2019, 30 (03) : 341 - +
  • [37] DEGENERATIVE SPONDYLOLISTHESIS OF THE LUMBAR SPINE
    SCHMITZ, B
    ANTONIADIS, A
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 1986, 124 (04): : 452 - 453
  • [38] Surgical Versus Nonsurgical Management of Degenerative Joint Disease
    Renapurkar, Shravan Kumar
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2018, 30 (03) : 291 - +
  • [39] Surgical treatment of adult degenerative spondylolisthesis by instrumented transforaminal lumbar interbody fusion in the Han nationality
    Xu, Hao
    Tang, Hao
    Li, Zhonghai
    JOURNAL OF NEUROSURGERY-SPINE, 2009, 10 (05) : 496 - 499
  • [40] Predictive Factors Affecting Surgical Outcomes in Patients with Degenerative Lumbar Spondylolisthesis
    Inose, Hiroyuki
    Kato, Tsuyoshi
    Onuma, Hiroaki
    Morishita, Shingo
    Matsukura, Yu
    Yuasa, Masato
    Hirai, Takashi
    Yoshii, Toshitaka
    Okawa, Atsushi
    SPINE, 2021, 46 (09) : 610 - 616